Literature DB >> 25071286

Angiolymphoid hyperplasia with eosinophilia mimicking multiple cylindromas: a rare case report.

Sheikh Manzoor Ahmad1, Gh Mohiuddin Wani1, Bilquees Khursheed1, Seema Qayoom1.   

Abstract

Angiolymphoid hyperplasia with eosinophilia (ALHE) is a rare and idiopathic vascular disorder. It is characterized by red to brown papules and nodules, typically localized on the head and neck, particularly around the ear as singular or multiple lesions. Although ALHE is a benign disease, lesions are often persistent and difficult to eradicate. Young to middle age women are more commonly affected. The histological examination corresponds to a florid vascular proliferation with atypical endothelial cells surrounded by a lymphocytic and eosinophilic infiltrate. We describe an elderly male with multiple nodular lesions over the scalp mimicking cylindromas; the histological examination was consistent with ALHE.

Entities:  

Keywords:  Angiolymphoid hyperplasia; eosinophilia; epitheloid hemangioma; scalp

Year:  2014        PMID: 25071286      PMCID: PMC4103303          DOI: 10.4103/0019-5154.135542

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN: 0019-5154            Impact factor:   1.494


  12 in total

1.  Angiolymphoid hyperplasia with eosinophilia associated with anomalous dilatation of occipital artery: IL-5 and VEGF expression of lesional mast cells.

Authors:  Mikako Aoki; Yoichi Kimura; Toshio Kusunoki; Shigeyuki Tahara; Seiji Kawanah
Journal:  Arch Dermatol       Date:  2002-07

2.  Angiolymphoid hyperplasia with eosinophilia associated with pregnancy: a case report and review of the literature.

Authors:  Neda Zarrin-Khameh; James E Spoden; Ruc M Tran
Journal:  Arch Pathol Lab Med       Date:  2005-09       Impact factor: 5.534

Review 3.  Angiolymphoid hyperplasia with eosinophilia and nephrotic syndrome.

Authors:  Maryam Azizzadeh; Mohammad Reza Namazi; Ladan Dastghaib; Fatemeh Sari-Aslani
Journal:  Int J Dermatol       Date:  2005-03       Impact factor: 2.736

4.  Angiolymphoid hyperplasia with eosinophilia in pregnancy.

Authors:  P Hollo; M Marschalko; G Sikos; J Harsing; A Horvath
Journal:  J Eur Acad Dermatol Venereol       Date:  2005-09       Impact factor: 6.166

5.  Subcutaneous angiolymphoid hyperplasia with eosinophilia.

Authors:  G C Wells; I W Whimster
Journal:  Br J Dermatol       Date:  1969-01       Impact factor: 9.302

6.  Angiolymphoid hyperplasia with eosinophilia. A clinicopathologic study of 116 patients.

Authors:  T G Olsen; E B Helwig
Journal:  J Am Acad Dermatol       Date:  1985-05       Impact factor: 11.527

7.  Kimura's disease and angiolymphoid hyperplasia with eosinophilia: clinical and histopathologic differences.

Authors:  S I Chun; H G Ji
Journal:  J Am Acad Dermatol       Date:  1992-12       Impact factor: 11.527

8.  Angiolymphoid hyperplasia with eosinophilia.

Authors:  M Endo; M Shibata; I Iwamoto; H Suzuki; M Hayakawa
Journal:  Eur J Dermatol       Date:  1998 Apr-May       Impact factor: 3.328

9.  A Long-Term Follow-Up of Angiolymphoid Hyperplasia with Eosinophilia Treated by Corticosteroids: When a Traditional Therapy is Still Up-to-Date.

Authors:  Serena Lembo; Anna Balato; Teresa Cirillo; Nicola Balato
Journal:  Case Rep Dermatol       Date:  2011-03-05

10.  Angiolymphoid hyperplasia with eosinophilia: atypical appearance in an older patient.

Authors:  Ozlem Karabudak; Oktay Taskapan; Onder Bozdogan; Bilal Dogan
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

View more
  2 in total

1.  Angiolymphoid Hyperplasia with Eosinophilia with Clinical Presentation Concerning for Juvenile Temporal Arteritis.

Authors:  Emily Li; John Sinard; Alberto Distefano; Mahsa Sohrab
Journal:  Ocul Oncol Pathol       Date:  2019-06-28

2.  Angiolymphoid hyperplasia with eosinophilia versus Kimura's disease: a case report and a clinical and histopathological comparison.

Authors:  Julien Totti de Bastos; Camila Roos Mariano da Rocha; Priscila Mara Chaves E Silva; Bruno Messias Pires de Freitas; Flávia de Freire Cassia; João Carlos Regazzi Avelleira
Journal:  An Bras Dermatol       Date:  2017 May-Jun       Impact factor: 1.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.